New balloon aims to clear clogged heart stents

NCT ID NCT07159087

ENROLLING_BY_INVITATION Disease control Sponsor: Genoss Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares a new drug-coated balloon (Genoss SCB) to an existing one (SeQuent Please NEO) for treating coronary arteries that have re-narrowed after stenting. About 94 adults with this condition will be randomly assigned to receive one of the two balloons during a standard heart procedure. The main goal is to see which balloon better keeps the artery open six months later, as measured by a special X-ray.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Sirolimus-coated balloon catheter (Genoss SCB) compared to Paclitaxel-coated balloon catheter (SeQuent Please NEO)
What this could lead to: If it works, this could offer a better option for treating re-narrowed heart arteries after stenting, potentially reducing the need for repeat procedures.
What could go wrong: This is a small, early-stage trial with only 94 patients. The new balloon may not prove superior or could have unexpected side effects. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary restenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERIAL DISEASE (CAD)

Contacts and locations

Locations

Seoul National University Bundang Hospital

Gyeonggi-do, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.